Structural Formula (Image 1)
Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-2696
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 71335-2696). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (Image 2)
Image (Image 3)
Image (Image 4)
Image (Image 5)
Image (Image 6)
Image (Image 7)
Label (Lbl713352696)
Each extended-release capsule contains 30 mg of Cyclobenzaprine Hydrochloride. The recommended dosage for adults is one capsule taken once daily at approximately the same time each day. The medication should be stored at 25°C (77°F) with excursions permitted to 15°-30°C (59°-86°F). It is advised to keep the capsules in a tight, light-resistant container and to keep all drugs out of the reach of children. The product is manufactured by Teva Pharmaceuticals USA, Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
